Intervacc Future Growth
Future criteria checks 2/6
Intervacc is forecast to grow earnings and revenue by 26.6% and 104.9% per annum respectively while EPS is expected to grow by 26.3% per annum.
Key information
26.6%
Earnings growth rate
26.3%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | 104.9% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 113 | -38 | -40 | -38 | 1 |
| 12/31/2025 | 35 | -64 | -67 | -65 | 1 |
| 12/31/2024 | 13 | -74 | -59 | -58 | 1 |
| 9/30/2024 | 9 | -77 | -49 | -49 | N/A |
| 6/30/2024 | 10 | -103 | -50 | -49 | N/A |
| 3/31/2024 | 9 | -103 | -54 | -52 | N/A |
| 12/31/2023 | 8 | -103 | -48 | -46 | N/A |
| 9/30/2023 | 10 | -106 | -57 | -55 | N/A |
| 6/30/2023 | 10 | -73 | -60 | -57 | N/A |
| 3/31/2023 | 12 | -71 | -65 | -62 | N/A |
| 12/31/2022 | 12 | -64 | -76 | -70 | N/A |
| 9/30/2022 | 10 | -50 | -70 | -57 | N/A |
| 6/30/2022 | 10 | -44 | -65 | -47 | N/A |
| 3/31/2022 | 9 | -34 | -55 | -33 | N/A |
| 12/31/2021 | 9 | -29 | -49 | -25 | N/A |
| 9/30/2021 | 9 | -28 | -43 | -24 | N/A |
| 6/30/2021 | 8 | -26 | -38 | -22 | N/A |
| 3/31/2021 | 7 | -26 | -36 | -23 | N/A |
| 12/31/2020 | 7 | -26 | -31 | -20 | N/A |
| 9/30/2020 | 7 | -26 | -35 | -18 | N/A |
| 6/30/2020 | 8 | -26 | -39 | -15 | N/A |
| 3/31/2020 | 9 | -29 | -45 | -10 | N/A |
| 12/31/2019 | 14 | -28 | -42 | -3 | N/A |
| 9/30/2019 | 16 | -27 | -40 | 0 | N/A |
| 6/30/2019 | 26 | -26 | -29 | 6 | N/A |
| 3/31/2019 | 41 | -29 | -28 | 0 | N/A |
| 12/31/2018 | 38 | -27 | -28 | -4 | N/A |
| 9/30/2018 | 38 | -27 | -32 | -12 | N/A |
| 6/30/2018 | 38 | -24 | N/A | -17 | N/A |
| 3/31/2018 | 43 | -16 | N/A | -28 | N/A |
| 12/31/2017 | 50 | -13 | N/A | -19 | N/A |
| 9/30/2017 | 52 | -11 | N/A | -17 | N/A |
| 6/30/2017 | 56 | -9 | N/A | -23 | N/A |
| 3/31/2017 | 63 | -6 | N/A | -1 | N/A |
| 12/31/2016 | 58 | -7 | N/A | -4 | N/A |
| 12/31/2015 | 65 | 0 | N/A | -19 | N/A |
| 12/31/2014 | 80 | 9 | N/A | N/A | N/A |
| 12/31/2013 | 1 | -2 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2E9 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2E9 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2E9 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2E9's revenue (104.9% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 2E9's revenue (104.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 2E9's Return on Equity is forecast to be high in 3 years time